Niagen Bioscience, Inc.
NAGE- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001386570
No open-market purchases or sales by Niagen Bioscience, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $102.1M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Niagen Bioscience, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 101 | 1 | 86 | −14 |
| Shares | 20.4M | 37 | 20.5M | +127.5K (+0.6%) |
| Value | $201.0M | $0 | $129.0M | −$72.0M (−35.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Niagen Bioscience, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 32,264 | $203.0K | 0.00% |
| SG Americas Securities, LLC | 20,487 | $128.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 10,769 | $68.0K | 0.00% |
| Sandy Spring Bank | 3,500 | $22.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 467 | $3.00K | 0.00% |
| First Horizon Advisors, Inc. | 37 | $0 | 0.00% |
Sold out (20)
Institutions that held Niagen Bioscience, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| New Thinking (Hong Kong) Investment Management Co. Ltd | 137,614 | $1.36M |
| Jacob Asset Management of New York LLC | 84,000 | $828.0K |
| Cubist Systematic Strategies, LLC | 56,453 | $557.0K |
| Tibra Equities Europe Ltd | 39,000 | $385.0K |
| Russell Investments Group, Ltd. | 37,026 | $365.0K |
| Squarepoint Ops LLC | 33,581 | $331.0K |
| Old Mission Capital LLC | 30,946 | $305.0K |
| Los Angeles Capital Management LLC | 30,495 | $301.0K |
| Keebeck Alpha, LP | 21,069 | $208.0K |
| Ergoteles LLC | 13,400 | $132.0K |
| ExodusPoint Capital Management, LP | 12,792 | $126.0K |
| XTX Topco Ltd | 12,528 | $124.0K |
| ProShare Advisors LLC | 12,158 | $120.0K |
| Algert Global LLC | 12,030 | $119.0K |
| Pinz Capital Management, LP | 12,100 | $119.0K |
| Wolverine Trading, LLC | 11,916 | $113.0K |
| Carroll Financial Associates, Inc. | 6,605 | $65.0K |
| Geneos Wealth Management Inc. | 2,950 | $27.0K |
| Panagora Asset Management Inc | 863 | $9.00K |
| Parallel Advisors, LLC | 100 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Niagen Bioscience, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Horizon Corp | 37 | $0 |